Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2003;23:1091-1097
Published online before print April 24, 2003, doi: 10.1161/01.ATV.0000072966.23250.1E
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
23/6/1091    most recent
01.ATV.0000072966.23250.1Ev1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Björkman, J.-A.
Right arrow Articles by Jern, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Björkman, J.-A.
Right arrow Articles by Jern, C.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*PHENYLEPHRINE
Related Collections
Right arrow Exercise/exercise testing/rehabilitation
Right arrow Coagulation and fibronolysis
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2003;23:1091.)
© 2003 American Heart Association, Inc.


Thrombosis

Cardiac Sympathetic Nerve Stimulation Triggers Coronary t-PA Release

Jan-Arne Björkman; Sverker Jern; Christina Jern

From AstraZeneca R&D Mölndal (J.-A.B.), Mölndal; The Cardiovascular Institute (J.-A.B., S.J., C.J.), Clinical Experimental Research Laboratory, Sahlgrenska University Hospital/Östra, Göteborg University; and Institute of Clinical Neuroscience (C.J.), Sahlgrenska University Hospital/Sahlgrenska, Göteborg University, Sweden.

Correspondence to Christina Jern, MD, PhD, Clinical Experimental Research Laboratory, Sahlgrenska University Hospital/Östra, Göteborg University, S-416 85 Göteborg, Sweden. E-mail christina.jern{at}neuro.gu.se

Objective— This study was undertaken to determine whether stimulation of sympathetic cardiac nerves induces release of the thrombolytic enzyme tissue-type plasminogen activator (t-PA) in the coronary vascular bed.

Methods and Results— Anesthetized pigs were studied in an open chest model. Bilateral vagotomy was performed, and sympathetic cardiac nerves were activated by electrical stimulation (1 and 8 Hz). To evaluate possible mediating effects of increased heart rate and enhanced local blood flow, tachycardia was induced by pacing and hyperemia by local infusion of sodium nitroprusside and clevedipine. Furthermore, to study the effects of {alpha}- and ß-adrenergic receptor stimulation, phenylephrine and isoprenaline were infused locally. In response to low- and high-frequency sympathetic stimulation, mean coronary net release of total t-PA increased approximately 6- and 25-fold, respectively. Active t-PA showed a similar response pattern. Neither tachycardia nor coronary hyperemia stimulated t-PA release. In contrast, ß-adrenergic stimulation by isoprenaline induced an approximately 6-fold increase in coronary t-PA release, whereas no significant change in release rates occurred in response to {alpha}-adrenergic stimulation by phenylephrine.

Conclusions— Stimulation of cardiac sympathetic nerves induces a marked coronary release of t-PA, and part of this response may be mediated through stimulation of ß-adrenergic receptors.


Key Words: tissue-type plasminogen activator • sympathetic nerves • adrenergic • coronary • pigs




This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
U. Schaefer, S. Vorlova, T. Machida, J. P. Melchor, S. Strickland, and R. Levi
Modulation of Sympathetic Activity by Tissue Plasminogen Activator Is Independent of Plasminogen and Urokinase
J. Pharmacol. Exp. Ther., July 1, 2007; 322(1): 265 - 273.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
U. Schaefer, T. Machida, S. Vorlova, S. Strickland, and R. Levi
The plasminogen activator system modulates sympathetic nerve function
J. Exp. Med., September 4, 2006; 203(9): 2191 - 2200.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
Z. Hao, C. Guo, X. Jiang, S. Krueger, T. Pietri, S. Dufour, R. E. Cone, and J. O'Rourke
New transgenic evidence for a system of sympathetic axons able to express tissue plasminogen activator (t-PA) within arterial/arteriolar walls
Blood, July 1, 2006; 108(1): 200 - 202.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
W. Ridderstrale, E. Ulfhammer, S. Jern, and T. Hrafnkelsdottir
Impaired Capacity for Stimulated Fibrinolysis in Primary Hypertension Is Restored by Antihypertensive Therapy
Hypertension, April 1, 2006; 47(4): 686 - 691.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
J. J. Oliver, D. J. Webb, and D. E. Newby
Stimulated Tissue Plasminogen Activator Release as a Marker of Endothelial Function in Humans
Arterioscler Thromb Vasc Biol, December 1, 2005; 25(12): 2470 - 2479.
[Abstract] [Full Text] [PDF]